title: Human esophageal myofibroblasts secrete proinflammatory cytokines in response to acid and Toll-like receptor 4 ligands.
abstract: The pathophysiology of esophageal injury, repair, and inflammation in gastroesophageal reflux-disease (GERD) is complex. Whereas most studies have focused on the epithelial response to GERD injury, we are interested in the stromal response. We hypothesized that subepithelial esophageal myofibroblasts in GERD secrete proinflammatory cytokines in response to injurious agents encountered via epithelial barrier breaches or through dilated epithelial intercellular spaces. We determined the percentage of myofibroblasts [-smooth muscle actin (-SMA)+vimentin+CD31-] in the subepithelial GERD and normal esophageal stroma by immunomorphologic analysis. We performed -SMA coimmunostaining with IL-6 and p65. We established and characterized primary cultures of -SMA+vimentin+CD31-CD45- human esophageal myofibroblasts (HuEso MFs). We modeled GERD by treatment with pH 4.5-acidified media and Toll-like receptor 4 (TLR4) ligands, LPS and high-mobility group box 1 protein (HMGB1), and determined myofibroblast cytokine secretion in response to GERD injury. We demonstrate that spindle-shaped cell myofibroblasts are located near the basement membrane of stratified squamous epithelium in normal esophagus. We identify an increase in subepithelial myofibroblasts and activation of proinflammatory pathways in patients with GERD. Primary cultures of stromal cells obtained from normal esophagus retain myofibroblast morphology and express the acid receptor transient receptor potential channel vanilloid subfamily 1 (TRPV1) and TLR4. HuEso MFs stimulated with acid and TLR4 agonists LPS and HMGB1 increase IL-6 and IL-8 secretion via TRPV1 and NF-B activation. Our work implicates a role for human subepithelial stromal cells in the pathogenesis of GERD-related esophageal injury. Findings of this study can be extended to the investigation of epithelial-stromal interactions in inflammatory esophageal mucosal disorders.
authors.forename: Matthew
authors.initials: M
authors.lastname: Gargus
authors.forename: Chao
authors.initials: C
authors.lastname: Niu
authors.forename: John G
authors.initials: JG
authors.lastname: Vallone
authors.forename: Jana
authors.initials: J
authors.lastname: Binkley
authors.forename: Deborah C
authors.initials: DC
authors.lastname: Rubin
authors.forename: Anisa
authors.initials: A
authors.lastname: Shaker
mesh_terms: D000199:Actins / Q000378:metabolism*; D001485:Basement Membrane / Q000378:metabolism / Q000473:pathology; D018929:Cell Culture Techniques; D004947:Esophagus / Q000378:metabolism / Q000473:pathology; D005764:Gastroesophageal Reflux / Q000378:metabolism / Q000473:pathology; D024243:HMGB1 Protein / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D016209:Interleukin-8 / Q000378:metabolism; D058628:Myofibroblasts / Q000378:metabolism / Q000473:pathology; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000378:metabolism; D013268:Stimulation, Chemical; D051197:Toll-Like Receptor 4 / Q000378:metabolism*; D014746:Vimentin / Q000378:metabolism
chemical_list: C541116:ACTA2 protein, human; D000199:Actins; D024243:HMGB1 Protein; D015850:Interleukin-6; D016209:Interleukin-8; D019408:Platelet Endothelial Cell Adhesion Molecule-1; C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4; D014746:Vimentin